INTERPARFUMS SA (ITP.PA) Stock Fundamental Analysis
EPA:ITP - Euronext Paris - Matif - FR0004024222 - Common Stock - Currency: EUR
Overall ITP gets a fundamental rating of 5 out of 10. We evaluated ITP against 13 industry peers in the Personal Care Products industry. Both the health and profitability get an excellent rating, making ITP a very profitable company, without any liquidiy or solvency issues. ITP is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ITP was profitable.
ITP had a positive operating cash flow in the past year.
ITP had positive earnings in each of the past 5 years.
Each year in the past 5 years ITP had a positive operating cash flow.
1.2 Ratios
ITP's Return On Assets of 11.64% is fine compared to the rest of the industry. ITP outperforms 76.92% of its industry peers.
Looking at the Return On Equity, with a value of 17.49%, ITP is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
ITP has a better Return On Invested Capital (15.44%) than 76.92% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ITP is in line with the industry average of 11.95%.
The last Return On Invested Capital (15.44%) for ITP is above the 3 year average (13.59%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.64% | ||
| ROE | 17.49% | ||
| ROIC | 15.44% |
ROA(3y)10.33%
ROA(5y)8.88%
ROE(3y)16.15%
ROE(5y)13.13%
ROIC(3y)13.59%
ROIC(5y)11.74%
1.3 Margins
The Profit Margin of ITP (13.43%) is better than 76.92% of its industry peers.
In the last couple of years the Profit Margin of ITP has grown nicely.
ITP's Operating Margin of 18.91% is fine compared to the rest of the industry. ITP outperforms 69.23% of its industry peers.
ITP's Operating Margin has improved in the last couple of years.
ITP's Gross Margin of 65.74% is fine compared to the rest of the industry. ITP outperforms 69.23% of its industry peers.
In the last couple of years the Gross Margin of ITP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.91% | ||
| PM (TTM) | 13.43% | ||
| GM | 65.74% |
OM growth 3Y17.54%
OM growth 5Y7.36%
PM growth 3Y21.18%
PM growth 5Y7.51%
GM growth 3Y2.82%
GM growth 5Y0.61%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ITP is creating value.
ITP has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ITP has more shares outstanding
The debt/assets ratio for ITP has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 8.32 indicates that ITP is not in any danger for bankruptcy at the moment.
The Altman-Z score of ITP (8.32) is better than 92.31% of its industry peers.
ITP has a debt to FCF ratio of 3.01. This is a good value and a sign of high solvency as ITP would need 3.01 years to pay back of all of its debts.
ITP has a Debt to FCF ratio of 3.01. This is comparable to the rest of the industry: ITP outperforms 53.85% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that ITP is not too dependend on debt financing.
ITP has a Debt to Equity ratio of 0.15. This is amongst the best in the industry. ITP outperforms 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 3.01 | ||
| Altman-Z | 8.32 |
ROIC/WACC2.05
WACC7.52%
2.3 Liquidity
ITP has a Current Ratio of 2.57. This indicates that ITP is financially healthy and has no problem in meeting its short term obligations.
ITP's Current ratio of 2.57 is amongst the best of the industry. ITP outperforms 100.00% of its industry peers.
ITP has a Quick Ratio of 1.37. This is a normal value and indicates that ITP is financially healthy and should not expect problems in meeting its short term obligations.
ITP has a better Quick ratio (1.37) than 92.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.57 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
The earnings per share for ITP have decreased strongly by -18.24% in the last year.
The Earnings Per Share has been growing by 18.13% on average over the past years. This is quite good.
Looking at the last year, ITP shows a small growth in Revenue. The Revenue has grown by 5.22% in the last year.
ITP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.89% yearly.
EPS 1Y (TTM)-18.24%
EPS 3Y50.42%
EPS 5Y18.13%
EPS Q2Q%-18.37%
Revenue 1Y (TTM)5.22%
Revenue growth 3Y29.54%
Revenue growth 5Y11.89%
Sales Q2Q%6.69%
3.2 Future
ITP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.10% yearly.
Based on estimates for the next years, ITP will show a small growth in Revenue. The Revenue will grow by 7.41% on average per year.
EPS Next Y9.88%
EPS Next 2Y7.5%
EPS Next 3Y6.74%
EPS Next 5Y15.1%
Revenue Next Year9.86%
Revenue Next 2Y7.32%
Revenue Next 3Y7.08%
Revenue Next 5Y7.41%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
ITP is valuated quite expensively with a Price/Earnings ratio of 26.48.
Compared to the rest of the industry, the Price/Earnings ratio of ITP is on the same level as its industry peers.
ITP's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.89.
Based on the Price/Forward Earnings ratio of 22.43, the valuation of ITP can be described as rather expensive.
Based on the Price/Forward Earnings ratio, ITP is valued a bit more expensive than 61.54% of the companies in the same industry.
ITP is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.98, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.48 | ||
| Fwd PE | 22.43 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ITP indicates a rather expensive valuation: ITP more expensive than 92.31% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ITP is valued expensively inside the industry as 92.31% of the companies are valued cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 75.45 | ||
| EV/EBITDA | 19.93 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ITP does not grow enough to justify the current Price/Earnings ratio.
ITP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.68
PEG (5Y)1.46
EPS Next 2Y7.5%
EPS Next 3Y6.74%
5. Dividend
5.1 Amount
ITP has a Yearly Dividend Yield of 2.81%. Purely for dividend investing, there may be better candidates out there.
ITP's Dividend Yield is a higher than the industry average which is at 2.39.
Compared to an average S&P500 Dividend Yield of 2.39, ITP has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.81% |
5.2 History
On average, the dividend of ITP grows each year by 19.21%, which is quite nice.
Dividend Growth(5Y)19.21%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
71.67% of the earnings are spent on dividend by ITP. This is not a sustainable payout ratio.
The dividend of ITP is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP71.67%
EPS Next 2Y7.5%
EPS Next 3Y6.74%
EPA:ITP (3/27/2025, 11:33:40 AM)
41.05
-0.15 (-0.36%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners11.39%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap3.12B
Analysts78.46
Price Target50.32 (22.58%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.81% |
Yearly Dividend0.91
Dividend Growth(5Y)19.21%
DP71.67%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.75%
PT rev (3m)-1.63%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.48 | ||
| Fwd PE | 22.43 | ||
| P/S | 3.79 | ||
| P/FCF | 75.45 | ||
| P/OCF | 63.99 | ||
| P/B | 4.93 | ||
| P/tB | 7.76 | ||
| EV/EBITDA | 19.93 |
EPS(TTM)1.55
EY3.78%
EPS(NY)1.83
Fwd EY4.46%
FCF(TTM)0.54
FCFY1.33%
OCF(TTM)0.64
OCFY1.56%
SpS10.84
BVpS8.32
TBVpS5.29
PEG (NY)2.68
PEG (5Y)1.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.64% | ||
| ROE | 17.49% | ||
| ROCE | 20.83% | ||
| ROIC | 15.44% | ||
| ROICexc | 16.88% | ||
| ROICexgc | 25.48% | ||
| OM | 18.91% | ||
| PM (TTM) | 13.43% | ||
| GM | 65.74% | ||
| FCFM | 5.02% |
ROA(3y)10.33%
ROA(5y)8.88%
ROE(3y)16.15%
ROE(5y)13.13%
ROIC(3y)13.59%
ROIC(5y)11.74%
ROICexc(3y)29.88%
ROICexc(5y)33.63%
ROICexgc(3y)2371.83%
ROICexgc(5y)N/A
ROCE(3y)18.33%
ROCE(5y)15.84%
ROICexcg growth 3YN/A
ROICexcg growth 5Y-7.2%
ROICexc growth 3Y-29.53%
ROICexc growth 5Y1.41%
OM growth 3Y17.54%
OM growth 5Y7.36%
PM growth 3Y21.18%
PM growth 5Y7.51%
GM growth 3Y2.82%
GM growth 5Y0.61%
F-Score7
Asset Turnover0.87
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 3.01 | ||
| Debt/EBITDA | 0.61 | ||
| Cap/Depr | 194.39% | ||
| Cap/Sales | 0.9% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.55% | ||
| Profit Quality | 37.38% | ||
| Current Ratio | 2.57 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 8.32 |
F-Score7
WACC7.52%
ROIC/WACC2.05
Cap/Depr(3y)362.77%
Cap/Depr(5y)231.57%
Cap/Sales(3y)9.26%
Cap/Sales(5y)6.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.24%
EPS 3Y50.42%
EPS 5Y18.13%
EPS Q2Q%-18.37%
EPS Next Y9.88%
EPS Next 2Y7.5%
EPS Next 3Y6.74%
EPS Next 5Y15.1%
Revenue 1Y (TTM)5.22%
Revenue growth 3Y29.54%
Revenue growth 5Y11.89%
Sales Q2Q%6.69%
Revenue Next Year9.86%
Revenue Next 2Y7.32%
Revenue Next 3Y7.08%
Revenue Next 5Y7.41%
EBIT growth 1Y-7.54%
EBIT growth 3Y52.25%
EBIT growth 5Y20.13%
EBIT Next Year24.45%
EBIT Next 3Y12.03%
EBIT Next 5Y14.67%
FCF growth 1Y65.89%
FCF growth 3Y25.17%
FCF growth 5Y8.8%
OCF growth 1Y-25.21%
OCF growth 3Y22.48%
OCF growth 5Y11.18%